Target Name: MIR548I1
NCBI ID: G100302204
Review Report on MIR548I1 Target / Biomarker Content of Review Report on MIR548I1 Target / Biomarker
MIR548I1
Other Name(s): hsa-mir-548i-1 | mir-548i-1 | MIR548I-1 | MIRN548I1 | microRNA 548i-1 | MicroRNA 548i-1 | hsa-miR-548i

MIR548I1: A Drug Target / Disease Biomarker

MIR548I1 is a protein that is expressed in various tissues throughout the body. It is a member of the integrin alpha-2 (IAAG) family, which is a subgroup of the integrin superfamily. IAAG proteins are involved in many different cellular processes in the body, including cell adhesion, migration, and invasion.

One of the things that makes MIR548I1 an interesting potential drug target is its role in cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. MIR548I1 is involved in the formation of tight junctions, which are the weakest type of cell-cell adhesion. These junctions allow cells to communicate with each other and to form tissues that are strong and stable.

Another way that MIR548I1 could be used as a drug target is its role in cancer. Many studies have suggested that MIR548I1 is involved in the development and progression of many different types of cancer. For example, MIR548I1 has been shown to be overexpressed in many types of cancer, including breast, ovarian, and prostate cancer. This suggests that targeting MIR548I1 could be a effective way to treat these cancers.

In addition to its role in cell adhesion and cancer, MIR548I1 is also interesting as a potential biomarker. Many researchers have used MIR548I1 as a target for studying the effects of drugs on cancer cells. By measuring the level of MIR548I1 in cancer cells, researchers can get a sense of how a drug is affecting those cells. This could be a useful way to monitor the effectiveness of a drug and to identify potential side effects.

Overall, MIR548I1 is a protein that is involved in many important cellular processes in the body. As a potential drug target and biomarker, it is a promising target for the development of new treatments for a wide range of diseases.

Protein Name: MicroRNA 548i-1

The "MIR548I1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR548I1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR548I2 | MIR548I3 | MIR548I4 | MIR548J | MIR548K | MIR548L | MIR548M | MIR548N | MIR548O | MIR548O2 | MIR548P | MIR548Q | MIR548S | MIR548T | MIR548U | MIR548V | MIR548W | MIR548X | MIR548Y | MIR549A | MIR550A1 | MIR550A2 | MIR550A3 | MIR550B1 | MIR550B2 | MIR551A | MIR551B | MIR552 | MIR553 | MIR554 | MIR555 | MIR556 | MIR557 | MIR5571 | MIR5572 | MIR5579 | MIR558 | MIR5580 | MIR5581 | MIR5582 | MIR5583-1 | MIR5584 | MIR5585 | MIR5586 | MIR5587 | MIR5588 | MIR5589 | MIR559 | MIR5590 | MIR5591 | MIR561 | MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1 | MIR5701-2 | MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572 | MIR573 | MIR5739 | MIR574